stakeholder panel on infant formula & adult nutritionals (spifan)
stakeholder panel on infant formula & adult nutritionals (spifan)
stakeholder panel on infant formula & adult nutritionals (spifan)
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
AOAC Staff:<br />
Delia Boyd<br />
Scott Coates<br />
Jennifer Diatz<br />
Anita Mishra<br />
I. WELCOME AND INTRODUCTIONS<br />
Darryl Sullivan, Chair of the Stakeholder Panel <strong>on</strong> Infant Formula and Adult Nutriti<strong>on</strong> (SPIFAN), welcomed the<br />
attendees/observers and called the meeting to order. Sullivan called attenti<strong>on</strong> to the AOAC policy<br />
documents for antitrust and volunteer c<strong>on</strong>flict of interest. He reviewed meeting materials c<strong>on</strong>sisting of the<br />
method books that were signed out to each attendee. Sullivan introduced J<strong>on</strong> DeVries, chair of the vitamin E<br />
working group and proceeded with the meeting.<br />
II. REVIEW DRAFT SMPR<br />
DeVries began the working group meeting with the applicability statement as described in the draft SMPR. It<br />
was determined that the applicability statement was the greatest c<strong>on</strong>cern. The term “methods maybe able<br />
to” should be added to the applicability statement.<br />
1. Applicability<br />
a. Delete the words “should be” and replace with “that are”<br />
b. At the end of paragraph add “may be desirable”<br />
2. Analytical Technique<br />
a. No change, keep as written<br />
3. Definiti<strong>on</strong>s<br />
a. No change, keep as written<br />
4. Method Performance Requirements<br />
a. In footnotes change “μ” to “m”<br />
5. System suitability tests and/or analytical quality c<strong>on</strong>trol<br />
a. No change, keep as written<br />
6. Reference Material(s):<br />
a. No change, keep as written<br />
7. Validati<strong>on</strong> Guidance:<br />
a. No change, keep as written<br />
8. Maximum Time‐To‐Signal:<br />
a. No change, keep as written<br />
Vitamin E Working Group Meeting Minutes PRE‐DECISIONAL ‐ DO NOT DISTRIBUTE<br />
Versi<strong>on</strong> 1<br />
Page 2